Código QR (código de barras bidimensional)

Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions

Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancers with adenocarcinoma being the most common subtype. Patients with stage IV NSCLC typically have poor prognosis. In these patients, identification of actionable genomic alterations allows for the selection of targeted th...

תיאור מלא

שמור ב:
Principais autores: Angel Kwan Qi Wong, Saqib Raza Khan, Danial Khan Hadi, Daniel Breadner, Mark David Vincent
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2026-01-01
סדרה:Current Oncology
נושאים:
non-small cell lung cancer
EGFR mutation
uncommon mutation
osimertinib
OCELOT clinical trial
גישה מקוונת:https://www.mdpi.com/1718-7729/33/1/55
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים